Table of Contents

|Articles|October 1, 2003

Pharmaceutical Executive

Pharmaceutical Executive-10-01-2003

Table of Contents

External Link - article-72790.pdf

Articles in this issue

over 22 years ago

Article

Balanced Scorecard for R&D

over 22 years ago

Article

Pharma's Value Proposition

over 22 years ago

Article

Sharing IP, Sharing Risk

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs

Inside the Expert Network Guiding TGN-S15 to Market

TrumpRx Expands to Offer Generic Medications

Rethinking Pharma's Go-to-Market Formula

Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing

Trending on PharmExec

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report

The Risks and Benefits of FDA Reviewing Real-Time Data

Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates

FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry

What Pharma Investors Should Expect in the Current Regulatory Environment